| Lara Mcfadden, | |
|
1410 S Kansas Ave, Newton, KS 67114-5302 | |
| (316) 284-3725 | |
| (316) 284-3728 |
| Full Name | Lara Mcfadden |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1410 S Kansas Ave, Newton, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821752619 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-103733 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lara Mcfadden, 9459 W Wyncroft St, Wichita, KS 67205-1426 Ph: (316) 390-9942 | Lara Mcfadden, 1410 S Kansas Ave, Newton, KS 67114-5302 Ph: (316) 284-3725 |
News Archive
YesDTC Holdings, Inc., a direct-to-consumer global distributor and marketer of consumer goods and products, announced today, the Company has acquired the rights to market the patented MediPendant™ medical alarm device from Medical Alarm Concepts Holding, Inc. via direct response television (DRTV).
The Hill Healthwatch: "The Centers for Medicare and Medicaid Services on Friday proposed new rules for the use of private contractors that work for states to audit Medicaid payments. The Recovery Audit Contractors will function similarly to the way they do in the Medicare program, where they audit payments that may have been underpaid or overpaid, and recover overpayments or correct underpayments. … Under the new law, states must establish Medicaid RAC programs by submitting state plan amendments to CMS by December 31" (Pecquet, 11/5).
The cholesterol-lowering drug pravastatin is highly effective in lowering the risk of heart attack and other cardiovascular events in patients with diabetes and chronic kidney disease (CKD), reports a study in the December Journal of the American Society of Nephrology.
The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
› Verified 7 days ago
Daniel Lindenmeyer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1410 S Kansas Ave, Newton, KS 67114 Phone: 316-284-3725 Fax: 316-284-3728 | |
Walter Barrett Jones, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 N Main St, Newton, KS 67114 Phone: 316-281-9356 | |
Brian Steventon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1216 N Main St, Newton, KS 67114 Phone: 316-283-6770 | |
Heath Allen Kerr, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1216 N Main St, Newton, KS 67114 Phone: 316-283-6770 Fax: 316-284-3719 | |
Miss Diana Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 N Main St, Newton, KS 67114 Phone: 316-281-9356 | |
Mrs. Christen Martens, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1216 N Main St, Newton, KS 67114 Phone: 316-283-6771 Fax: 316-284-3719 | |
Tina Reese, PHARMICIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 Fax: 316-283-1333 |